Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07307664) titled 'Increasing Germline Genetic Testing for Patients With Cancer' on Dec. 26, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Josh Peterson
Condition:
Hereditary Pancreatic Cancer
Conditions or Focus of Study
Hereditary Breast Cancer
Hereditary Colorectal Cancer
Intervention:
Behavioral: Implementation strategies
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: January 1, 2026
Target Sample Size: 1000
Countries of Recruitment:
United States
To know more, ...